Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
September-2020 Volume 44 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2020 Volume 44 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway

  • Authors:
    • Long Wen
    • Xiaoqian Zhang
    • Junling Zhang
    • Shanwen Chen
    • Yongchen Ma
    • Jianwen Hu
    • Taohua Yue
    • Jingui Wang
    • Jing Zhu
    • Tao Wu
    • Xin Wang
  • View Affiliations / Copyright

    Affiliations: Department of General Surgery, Peking University First Hospital, Beijing 100034, P.R. China, Department of Endoscopic Center, Peking University First Hospital, Beijing 100034, P.R. China
    Copyright: © Wen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1105-1115
    |
    Published online on: July 14, 2020
       https://doi.org/10.3892/or.2020.7687
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Paxillin (PXN) is a cytoplasmic protein that plays an important role in regulating focal adhesion, cytoskeletal rearrangements and cell motility. The present study aimed to investigate the role of PXN in the metastasis of human colorectal cancer (CRC) and its possible mechanisms. Immunohistochemical staining of tissues from 102 surgical CRC patients revealed that high PXN expression was positively correlated with tumour‑node‑metastasis (TNM) stage, lymph node metastasis, distant metastasis, and recurrence at distant sites after radical surgery. In 24 cases of stage IV CRC, PXN expression in liver metastasis was higher than that in the matched primary tumour. The knockdown of PXN inhibited the proliferation, migration and invasion potential of SW480 cells in vitro and in vivo. Transmission electron microscopy revealed the effect of PXN on ultrastructural characteristics, observed mainly in microvilli and desmosomes. The downregulation of PXN decreased the activation of extracellular regulated protein kinase (ERK) and suppressed the epithelial‑mesenchymal transition (EMT) process. Following the downregulation of PXN, the addition of an ERK activator or inhibitor restored or further suppressed EMT, respectively, accompanied by corresponding changes in cell migration and invasion. Collectively, the present results confirmed the important role of PXN in CRC metastasis and revealed that PXN regulated EMT progression via the ERK signalling pathway. PXN may represent a future therapeutic strategy to prevent the EMT‑associated progression and invasion of CRC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester R, Barzi A and Jemal A: Colorectal cancer statistics, 2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Cao H, Xu E, Liu H, Wan L and Lai M: Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review. Pathol Res Pract. 211:557–569. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Mizukoshi K, Okazawa Y, Haeno H, Koyama Y, Sulidan K, Komiyama H, Saeki H, Ohtsuji N, Ito Y, Kojima Y, et al: Metastatic seeding of human colon cancer cell clusters expressing the hybrid epithelial/mesenchymal state. Int J Cancer. 146:2547–2562. 2019. View Article : Google Scholar : PubMed/NCBI

5 

Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N and Papavassiliou AG: TGF-beta signalling in colon carcinogenesis. Cancer Lett. 314:1–7. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Li T, Zhu J, Wang X, Chen G, Sun L, Zuo S, Zhang J, Chen S, Ma J, Yao Z, et al: Long non-coding RNA lncTCF7 activates the Wnt/β-catenin pathway to promote metastasis and invasion in colorectal cancer. Oncol Lett. 14:7384–7390. 2017.PubMed/NCBI

7 

Hong SK, Park JR, Kwon OS, Kim KT, Bae GY and Cha HJ: Induction of integrin β3 by sustained ERK activity promotes the invasiveness of TGFβ-induced mesenchymal tumor cells. Cancer Lett. 376:339–346. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Tanahashi T, Osada S, Yamada A, Kato J, Yawata K, Mori R, Imai H, Sasaki Y, Saito S, Tanaka Y, et al: Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition. Int J Oncol. 42:556–564. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Smith BN, Burton LJ, Henderson V, Randle DD, Morton DJ, Smith BA, Taliaferro-Smith L, Nagappan P, Yates C, Zayzafoon M, et al: Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2. PLoS One. 9:e1049872014. View Article : Google Scholar : PubMed/NCBI

10 

Deakin NO and Turner CE: Paxillin comes of age. J Cell Sci. 121:2435–2444. 2008. View Article : Google Scholar : PubMed/NCBI

11 

López-ColoméLee-Rivera I, Benavides-Hidalgo R and López E: Paxillin: A crossroad in pathological cell migration. J Hematol Oncol. 10:502017. View Article : Google Scholar : PubMed/NCBI

12 

Zhao CJ, Du SK, Dang XB and Gong M: Expression of paxillin is correlated with clinical prognosis in colorectal cancer patients. Med Sci Monit. 21:1989–1995. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Du C, Wang X, Zhang J, Liu X, Zhu J and Liu Y: Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells. Oncol Rep. 35:409–417. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, Qiu MZ, Ren C, Zhang DS, Wang ZQ, Wang FH, et al: Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis. 34:803–811. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Joo D, Woo JS, Cho KH, Han SH, Min TS, Yang DC and Yun CH: Biphasic activation of extracellular signal-regulated kinase (ERK) 1/2 in epidermal growth factor (EGF)-stimulated SW480 colorectal cancer cells. BMB Rep. 49:220–225. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Takahashi E: The regulation of epithelial mesenchymal transition in ocular disorders. Nippon Ganka Gakkai Zasshi. 120:783–790. 2016.(In Japanese). PubMed/NCBI

17 

Yang HJ, Chen JZ, Zhang WL and Ding YQ: Focal adhesion plaque associated cytoskeletons are involved in the invasion and metastasis of human colorectal carcinoma. Cancer Invest. 28:127–134. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Ikuta D, Miyake T, Shimizu T, Sonoda H, Mukaisho KI, Tokuda A, Ueki T, Sugihara H and Tani M: Fibrosis in metastatic lymph nodes is clinically correlated to poor prognosis in colorectal cancer. Oncotarget. 9:29574–29586. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Takahashi H, Sakakura K, Kawabata-Iwakawa R, Rokudai S, Toyoda M, Nishiyama M and Chikamatsu K: Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Cancer Immunol Immunother. 64:1407–1417. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Mantonakis E, Giaginis C, Pikoulis E, Felekouras E, Patsouris E, Liakakos T, Papalampros E and Theocharis S: FAK, Src and p-Paxillin expression is decreased in liver metastasis of colorectal carcinoma patients. J BUON. 22:1097–1106. 2017.PubMed/NCBI

21 

Belluco C, Mammano E, Petricoin E, Prevedello L, Calvert V, Liotta L, Nitti D and Lise M: Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis. Clin Chim Acta. 357:180–183. 2005. View Article : Google Scholar : PubMed/NCBI

22 

Deakin NO, Pignatelli J and Turner CE: Diverse roles for the paxillin family of proteins in cancer. Genes Cancer. 3:362–370. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Devreotes P and Horwitz AR: Signaling networks that regulate cell migration. Cold Spring Harb Perspect Biol. 7:a0059592015. View Article : Google Scholar : PubMed/NCBI

24 

Meng Y, Lu Z, Yu S, Zhang Q, Ma Y and Chen J: Ezrin promotes invasion and metastasis of pancreatic cancer cells. J Transl Med. 8:612010. View Article : Google Scholar : PubMed/NCBI

25 

Ren J, Hamada J, Okada F, Takeichi N, Morikawa K, Hosokawa M and Kobayashi H: Correlation between the presence of microvilli and the growth or metastatic potential of tumor cells. Jpn J Cancer Res. 81:920–926. 1990. View Article : Google Scholar : PubMed/NCBI

26 

Hodge RG and Ridley AJ: Regulating Rho GTPases and their regulators. Nat Rev Mol Cell Biol. 17:496–510. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Barros JC and Marshall CJ: Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton. J Cell Sci. 118:1663–1671. 2005. View Article : Google Scholar : PubMed/NCBI

28 

Alroy J, Pauli BU and Weinstein RS: Correlation between numbers of desmosomes and the aggressiveness of transitional cell carcinoma in human urinary bladder. Cancer. 47:104–112. 1981. View Article : Google Scholar : PubMed/NCBI

29 

Collins JE, Taylor I and Garrod DR: A study of desmosomes in colorectal carcinoma. Br J Cancer. 62:796–805. 1990. View Article : Google Scholar : PubMed/NCBI

30 

Tumbarello DA, Brown MC, Hetey SE and Turner CE: Regulation of paxillin family members during epithelial-mesenchymal transformation: A putative role for paxillin delta. J Cell Sci. 118:4849–4863. 2005. View Article : Google Scholar : PubMed/NCBI

31 

Kowtharapu BS, Murin R, Jünemann AGM and Stachs O: Role of corneal stromal cells on epithelial cell function during wound healing. Int J Mol Sci. 19:4642018. View Article : Google Scholar

32 

Takahashi E, Inoue T, Fujimoto T, Kojima S and Tanihara H: Epithelial mesenchymal transition-like phenomenon in trabecular meshwork cells. Exp Eye Res. 118:72–79. 2014. View Article : Google Scholar : PubMed/NCBI

33 

Deakin NO and Turner CE: Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis. Mol Biol Cell. 22:327–341. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Zouq NK, Keeble JA, Lindsay J, Valentijn AJ, Zhang L, Mills D, Turner CE, Streuli CH and Gilmore AP: FAK engages multiple pathways to maintain survival of fibroblasts and epithelia: Differential roles for paxillin and p130Cas. J Cell Sci. 122:357–367. 2009. View Article : Google Scholar : PubMed/NCBI

35 

Simpson CD, Anyiwe K and Schimmer AD: Anoikis resistance and tumor metastasis. Cancer Lett. 272:177–185. 2008. View Article : Google Scholar : PubMed/NCBI

36 

Stemmer V, de Craene B, Berx G and Behrens J: Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene. 27:5075–5080. 2008. View Article : Google Scholar : PubMed/NCBI

37 

Ha GH, Park JS and Breuer EK: TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. Cancer Lett. 332:63–73. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Subauste MC, Pertz O, Adamson ED, Turner CE, Junger S and Hahn KM: Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J Cell Biol. 165:371–381. 2004. View Article : Google Scholar : PubMed/NCBI

39 

Sen A, De Castro I, Defranco DB, Deng FM, Melamed J, Kapur P, Raj GV, Rossi R and Hammes SR: Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. J Clin Invest. 122:2469–2481. 2012. View Article : Google Scholar : PubMed/NCBI

40 

Ishibe S, Joly D, Zhu X and Cantley LG: Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis. Mol Cell. 12:1275–1285. 2003. View Article : Google Scholar : PubMed/NCBI

41 

Herreros L, Rodríguez-Fernandez JL, Brown MC, Alonso-Lebrero JL, Cabañas C, Sánchez-Madrid F, Longo N, Turner CE and Sanchez-Mateos P: Paxillin localizes to the lymphocyte microtubule organizing center and associates with the microtubule cytoskeleton. J Biol Chem. 275:26436–26440. 2000. View Article : Google Scholar : PubMed/NCBI

42 

Romanova LY, Hashimoto S, Chay KO, Blagosklonny MV, Sabe H and Mushinski JF: Phosphorylation of paxillin tyrosines 31 and 118 controls polarization and motility of lymphoid cells and is PMA-sensitive. J Cell Sci. 117:3759–3768. 2004. View Article : Google Scholar : PubMed/NCBI

43 

Rose DM, Han J and Ginsberg MH: Alpha4 integrins and the immune response. Immunol Rev. 186:118–124. 2002. View Article : Google Scholar : PubMed/NCBI

44 

Rhee I, Zhong MC, Reizis B, Cheong C and Veillette A: Control of dendritic cell migration, T cell-dependent immunity, and autoimmunity by protein tyrosine phosphatase PTPN12 expressed in dendritic cells. Mol Cell Biol. 34:888–899. 2014. View Article : Google Scholar : PubMed/NCBI

45 

Parsons SA, Sharma R, Roccamatisi DL, Zhang H, Petri B, Kubes P, Colarusso P and Patel KD: Endothelial paxillin and focal adhesion kinase (FAK) play a critical role in neutrophil transmigration. Eur J Immunol. 42:436–446. 2012. View Article : Google Scholar : PubMed/NCBI

46 

Zhang LL, Zhang LF and Shi YB: Down-regulated paxillin suppresses cell proliferation and invasion by inhibiting M2 macrophage polarization in colon cancer. Biol Chem. 399:1285–1295. 2018. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wen L, Zhang X, Zhang J, Chen S, Ma Y, Hu J, Yue T, Wang J, Zhu J, Wu T, Wu T, et al: Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway. Oncol Rep 44: 1105-1115, 2020.
APA
Wen, L., Zhang, X., Zhang, J., Chen, S., Ma, Y., Hu, J. ... Wang, X. (2020). Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway. Oncology Reports, 44, 1105-1115. https://doi.org/10.3892/or.2020.7687
MLA
Wen, L., Zhang, X., Zhang, J., Chen, S., Ma, Y., Hu, J., Yue, T., Wang, J., Zhu, J., Wu, T., Wang, X."Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway". Oncology Reports 44.3 (2020): 1105-1115.
Chicago
Wen, L., Zhang, X., Zhang, J., Chen, S., Ma, Y., Hu, J., Yue, T., Wang, J., Zhu, J., Wu, T., Wang, X."Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway". Oncology Reports 44, no. 3 (2020): 1105-1115. https://doi.org/10.3892/or.2020.7687
Copy and paste a formatted citation
x
Spandidos Publications style
Wen L, Zhang X, Zhang J, Chen S, Ma Y, Hu J, Yue T, Wang J, Zhu J, Wu T, Wu T, et al: Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway. Oncol Rep 44: 1105-1115, 2020.
APA
Wen, L., Zhang, X., Zhang, J., Chen, S., Ma, Y., Hu, J. ... Wang, X. (2020). Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway. Oncology Reports, 44, 1105-1115. https://doi.org/10.3892/or.2020.7687
MLA
Wen, L., Zhang, X., Zhang, J., Chen, S., Ma, Y., Hu, J., Yue, T., Wang, J., Zhu, J., Wu, T., Wang, X."Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway". Oncology Reports 44.3 (2020): 1105-1115.
Chicago
Wen, L., Zhang, X., Zhang, J., Chen, S., Ma, Y., Hu, J., Yue, T., Wang, J., Zhu, J., Wu, T., Wang, X."Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway". Oncology Reports 44, no. 3 (2020): 1105-1115. https://doi.org/10.3892/or.2020.7687
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team